Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0905519 on August 14, 2007

Published online before print August 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0905519v1
82/5/1106    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, P.
Right arrow Articles by Legler, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, P.
Right arrow Articles by Legler, D. F.
(Journal of Leukocyte Biology. 2007;82:1106-1114.)
© 2007 by Society for Leukocyte Biology

Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO

Petra Krause*, Eva Singer{dagger}, Paula I. Darley{ddagger}, Janosch Klebensberger{ddagger}, Marcus Groettrup*,§ and Daniel F. Legler*,1

* Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland;
{dagger} Klinikum Konstanz, Konstanz, Germany; and Divisions of
{ddagger} Microbial Ecology and
§ Immunology, Department of Biology, University of Konstanz, Konstanz, Germany

1 Correspondence: Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Unterseestrasse 47, CH-8280 Kreuzlingen, Switzerland. E-mail: daniel.legler{at}bitg.ch

The exclusive ability of dendritic cells (DCs) to stimulate primary and secondary immune responses favors the use of antigen-loaded human monocyte-derived DCs (MoDCs) in vaccinations against tumors. Previous studies demonstrated that PGE2 is fundamental during MoDC maturation to facilitate migration toward lymph node-derived chemokines. A recent study challenged the use of PGE2, as PGE2 induced IDO in mature MoDCs. In MoDCs compatible for clinical use, we now demonstrate that PGE2 is responsible for IDO induction if matured by soluble CD40 ligand, LPS, or cytokines. In contrast, IDO expression in MoDCs matured by TLR3 triggering occurs independently of PGE2. It is surprising that despite active IDO protein, MoDCs matured with PGE2 display a greater potential to stimulate naïve CD4+ and CD8+ T cell proliferation, which is not increased further by IDO inhibition. Moreover, we found elevated levels of tryptophanyl-tRNA-synthetase (TTS) in T cells cultured with PGE2-matured MoDCs. Our data demonstrate that PGE2 induces IDO in MoDCs but that T cell-stimulating capacities of PGE2-matured MoDCs overcome IDO activity, probably through TTS induction. As PGE2 is critical for DC migration and enhances the capability of MoDCs to induce T cell proliferation, we highly recommend supplementing DC maturation stimuli with PGE2 for use in clinical trials.

Key Words: cell proliferation • chemotaxis • vaccination




This article has been cited by other articles:


Home page
BloodHome page
S. Agaugue, E. Marcenaro, B. Ferranti, L. Moretta, and A. Moretta
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells
Blood, September 1, 2008; 112(5): 1776 - 1783.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.